Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
about
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study.Aspergillus infections in transplant recipients.Aminoglycoside-free interventional antibiotic management in patients undergoing haemopoietic stem cell transplantation.The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem.Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center studyAntiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.D-index: A New Scoring System in Febrile Neutropenic Patients for Predicting Invasive Fungal Infections.Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study.Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant.Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation.Recovery of mucosal-associated invariant T cells after myeloablative chemotherapy and autologous peripheral blood stem cell transplantation.Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection.Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells.Infectious complications in breast cancer patients undergoing peripheral blood stem cell transplantation: a single center retrospective analysis towards outpatient strategy.Cytomegalovirus Reactivation in Adult Recipients of Autologous Stem Cell Transplantation: a Single Center Experience.Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients.High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network.Two Ocular Infections during Conventional Chemotherapy in a Patient with Acute Lymphoblastic Leukemia: A Case Report.Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients.Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients.Infections during mobilizing chemotherapy and following autologous stem cell transplantation.Infectious complications in adult acute lymphoblastic leukemia (ALL): experience at one single center.Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial.Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients.Immune reconstitution, infectious complications and post transplant supportive care measures after autologous blood and marrow transplantation in children.Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience.
P2860
Q31437264-AEFA6A99-E885-4001-AC52-2DEA6C94C6C7Q33719294-A27091C4-7134-4446-9154-5EBC5A8CC92BQ34180913-07FA5CD0-F2B9-4898-9F6A-E0808756C97BQ34984415-9DD9A7FA-DF49-4FAF-B653-4D1468838F42Q35793055-F520E59A-FA8F-40FA-A19F-1EB9908993FDQ36367268-EF10D819-8A71-4101-B6C3-0D73C5D234A0Q36505508-1A0604B8-A33F-4E79-A0CF-96D0F98D8509Q37401327-260C9897-4310-493E-9E9E-88ABA4675A98Q38264990-F852A660-E00F-41D3-8225-F82231DEFD11Q38703120-D1404CF8-7BC3-40A3-BA3D-4D3AE59FF11EQ40432531-694A7951-1FAC-4949-A4D3-53E7967EE343Q40497285-1AFF5B5A-800C-45FC-87D8-CA525A94415FQ40517545-7411EB17-0B38-4EBA-94D5-3DDF47813ABEQ40554961-54686832-F89A-489C-B3B9-C01439A31FA9Q40590665-EC3F3282-D3FA-462A-AEDF-42CA95DA198FQ40984424-7161A868-F98C-4C9B-B77A-EC37044FDF2FQ42249128-E0A003AE-DA90-4877-B3F2-45639F26BF20Q42256487-95B8BCBE-0D19-4876-8529-592DAF56E6A6Q42541441-43FD2A8B-91C6-400C-96A3-E55A74D52FBFQ43690751-A11DDF8D-8624-4BC4-A853-73CBEA6D4221Q43855940-17217D6E-2C33-4B9E-9865-62F2F2DBB4E3Q43861734-106D5B36-5AD7-4DA8-A20F-380F26A83C37Q45061056-D020C675-09C6-4A63-AE97-3200E19EDB02Q46131298-08346F9F-5E8E-43E6-995B-906CA3BD1F9DQ47578597-5046546A-6F99-4097-B6E5-9119113BCF85Q47623120-1993C84C-4F3C-4441-8763-E558B500CF33Q53474437-429ECCAF-56F7-4EDA-9141-7F021D2FBF0B
P2860
Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Infectious complications after ...... splantation followed by G-CSF.
@en
type
label
Infectious complications after ...... splantation followed by G-CSF.
@en
prefLabel
Infectious complications after ...... splantation followed by G-CSF.
@en
P2093
P356
P1476
Infectious complications after ...... splantation followed by G-CSF.
@en
P2093
Centurioni R
Corvatta L
Montanari M
Offidani M
Olivieri A
P2888
P304
P356
10.1038/SJ.BMT.1702033
P407
P577
1999-11-01T00:00:00Z
P5875
P6179
1003992907